MIH
EVGN icon

Meitav Investment House’s Evogene EVGN Stock Holding History

Meitav Investment House’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,947
Closed -$77K – 430
2020
Q3 		$77K Sell
1,947
-25
-1% -$446 ﹤0.01% 390
2020
Q2 		$20K Hold
1,972
– – ﹤0.01% 382
2020
Q1 		$23K Hold
1,972
– – ﹤0.01% 370
2019
Q4 		$30K Sell
1,972
-5,213
-73% -$77.9K ﹤0.01% 420
2019
Q3 		$121K Buy
7,185
+1,811
+34% +$28.5K 0.01% 430
2019
Q2 		$87K Buy
5,374
+2,522
+88% +$46.7K 0.01% 421
2019
Q1 		$51K Buy
2,852
+880
+45% +$18.6K ﹤0.01% 384
2018
Q4 		$39K Sell
1,972
-895
-31% -$22.6K ﹤0.01% 330
2018
Q3 		$88K Hold
2,867
– – ﹤0.01% 433
2018
Q2 		$151K Buy
2,867
+880
+44% +$26.8K 0.01% 414
2018
Q1 		$63K Hold
1,987
– – ﹤0.01% 331
2017
Q4 		$61K Buy
+1,987
New +$78K ﹤0.01% 201

Other funds holding EVGN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Meitav Investment House's EVGN Position: Q4 2020 in Review

Meitav Investment House sold out of Evogene (EVGN) in Q4 2020, closing a stake of 1,947 shares — an estimated $77K sold.

Meitav Investment House first reported a position in EVGN in Q4 2017 and held it in 12 quarters. The position peaked at $151K in Q2 2018. 33 funds tracked by Wall St. Rank hold EVGN as of Q4 2020.

  • Meitav Investment House reported no remaining Evogene position as of Q4 2020 after selling out during the quarter.
  • Meitav Investment House sold 1,947 Evogene shares in Q4 2020, an estimated $77K.
  • Meitav Investment House first reported a position in Evogene in Q4 2017 and held it in 12 quarters.
  • Meitav Investment House's Evogene position peaked at $151K in Q2 2018.
  • 33 funds tracked by Wall St. Rank held Evogene as of Q4 2020.

Based on Meitav Investment House's 13F filing for Q4 2020, filed 2 Feb 2021.